IBI Investment House Ltd. (IL:IBI)
TASE:IBI
Top Page
Ibi Inv House
(TASE:IBI)
Select Model
Select Model
Rating:67Neutral
Price Target:
35,317.00
▲(19.35% Upside)
Action:DowngradedDate:03/27/26
The score is driven primarily by strong financial performance (growth, profitability, and cash generation), tempered by balance-sheet risk from higher 2025 debt. Technicals are the main drag due to weak momentum and trading below key moving averages, while valuation is supportive with a moderate P/E and solid dividend yield.
Positive Factors
Revenue Growth
The company recorded a material step-change in top-line in 2025 versus 2024, indicating durable demand expansion or successful scaling. Sustained revenue acceleration supports market share gains, capacity to invest in products and distribution, and long-term earnings power.
Negative Factors
2025 Debt Increase
A meaningful step-up in debt in 2025 reduces financial flexibility and raises refinancing and interest-rate exposure. If macro conditions tighten or earnings fluctuate, higher leverage can constrain capital allocation and heighten solvency risk over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The company recorded a material step-change in top-line in 2025 versus 2024, indicating durable demand expansion or successful scaling. Sustained revenue acceleration supports market share gains, capacity to invest in products and distribution, and long-term earnings power.
Read all positive factors
Ibi Inv House (IBI) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪4.66B
Dividend Yield3.92%
Average Volume (3M)16.58K
Price to Earnings (P/E)24.0
Beta (1Y)1.24
Revenue Growth46.14%
EPS Growth-17.83%
CountryIL
Employees937
SectorFinancial
Sector Strength70
IndustryFinancial - Conglomerates
Share Statistics
EPS (TTM)438.40
Shares Outstanding14,072,274
10 Day Avg. Volume11,015
30 Day Avg. Volume16,583
Financial Highlights & Ratios
PEG Ratio-4.59
Price to Book (P/B)4.57
Price to Sales (P/S)2.86
P/FCF Ratio14.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Ibi Inv House Business Overview & Revenue Model
Company Description
I.B.I Investment House Ltd. is a publicly owned holding investment firm with approximately NIS 11 billion ($2.63 billion) in assets under management. The firm provides its services to individuals and institutional clients. Through its subsidiaries...
Ibi Inv House Financial Statement Overview
Summary
Income Statement
86
Very Positive
Balance Sheet
72
Positive
Cash Flow
78
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.47B | 1.04B | 791.55M | 660.61M | 548.65M |
| Gross Profit | 1.40B | 696.21M | 511.24M | 417.09M | 357.00M |
| EBITDA | 494.39M | 368.28M | 281.08M | 212.29M | 227.69M |
| Net Income | 174.59M | 178.14M | 156.46M | 90.76M | 139.58M |
Balance Sheet | |||||
| Total Assets | 2.17B | 1.85B | 1.27B | 1.08B | 1.13B |
| Cash, Cash Equivalents and Short-Term Investments | 604.92M | 519.23M | 453.00M | 246.53M | 547.09M |
| Total Debt | 442.27M | 243.90M | 201.26M | 154.42M | 334.90M |
| Total Liabilities | 1.03B | 750.27M | 539.07M | 399.48M | 521.39M |
| Stockholders Equity | 918.42M | 899.76M | 686.62M | 640.44M | 575.47M |
Cash Flow | |||||
| Free Cash Flow | 290.24M | 218.35M | 207.56M | 45.23M | 190.60M |
| Operating Cash Flow | 307.53M | 249.28M | 269.65M | 61.11M | 197.55M |
| Investing Cash Flow | -100.26M | -97.88M | -269.38M | -44.08M | 36.90M |
| Financing Cash Flow | -178.80M | -141.00K | -37.48M | -80.76M | -196.36M |
Ibi Inv House Technical Analysis
Neutral
29590.00
Price Trends
36175.43
Negative
32604.62
Positive
27869.66
Positive
Market Momentum
-1340.07
Positive
40.72
Neutral
28.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:IBI, the sentiment is Neutral. The current price of 29590 is below the 20-day moving average (MA) of 36214.30, below the 50-day MA of 36175.43, and above the 200-day MA of 27869.66, indicating a neutral trend. The MACD of -1340.07 indicates Positive momentum. The RSI at 40.72 is Neutral, neither overbought nor oversold. The STOCH value of 28.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IL:IBI.
Ibi Inv House Peers Comparison
UnderperformOutperform
Sector (68)
IL:IBI
Ibi Inv House
33,100.00
15,254.29
85.48%
IL:FBRT
Fms
26,180.00
11,345.85
76.48%
IL:LAPD
Lapidoth Cap.
9,048.00
3,361.03
59.10%
IL:IDIN
Idi Insur
22,060.00
7,290.05
49.36%
IL:JBNK
Jerusalem
2,105.00
449.17
27.13%
IL:ATRY
Atreyu Cap
7,590.00
995.58
15.10%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.